These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 10528331
21. [Mechanism of action, clinical indication and results of treatment of botulinum toxin]. Lagueny A, Burbaud P. Neurophysiol Clin; 1996; 26(4):216-26. PubMed ID: 8975111 [Abstract] [Full Text] [Related]
22. [Treatment of movement disorders using botulinum toxin]. Burgunder JM. Schweiz Med Wochenschr; 1992 Sep 05; 122(36):1311-6. PubMed ID: 1411387 [Abstract] [Full Text] [Related]
23. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations. Bhidayasiri R, Cardoso F, Truong DD. Eur J Neurol; 2006 Feb 05; 13 Suppl 1():21-9. PubMed ID: 16417594 [Abstract] [Full Text] [Related]
24. [Botulinum toxin in spasticity treatment]. Sławek J. Neurol Neurochir Pol; 1998 Feb 05; 32 Suppl 1():71-84. PubMed ID: 9608556 [Abstract] [Full Text] [Related]
25. [Botulism toxin in practice]. Durand A, Serment G. Ann Readapt Med Phys; 2003 Jul 05; 46(6):386-8. PubMed ID: 12928147 [Abstract] [Full Text] [Related]
26. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Rollnik JD, Matzke M, Wohlfarth K, Dengler R, Bigalke H. Eur Neurol; 2000 Jul 05; 43(1):9-12. PubMed ID: 10601802 [Abstract] [Full Text] [Related]
27. Stroke, spasticity, and botulinum toxin. Rowland LP. N Engl J Med; 2002 Aug 08; 347(6):382-3. PubMed ID: 12167679 [No Abstract] [Full Text] [Related]
28. [Treatment of writer's cramp and other forms of limb dystonias with botulinum toxin]. Bogucki A. Neurol Neurochir Pol; 1998 Aug 08; 32 Suppl 1():45-50. PubMed ID: 9608552 [Abstract] [Full Text] [Related]
29. Riolan's muscle: action and indications for botulinum toxin injection. Mackie IA. Eye (Lond); 2000 Jun 08; 14 ( Pt 3A)():347-52. PubMed ID: 11026998 [Abstract] [Full Text] [Related]
30. [Botulinium toxin in ENT]. Klap P. Ann Otolaryngol Chir Cervicofac; 2006 Dec 08; 123(6):306-11. PubMed ID: 17202988 [No Abstract] [Full Text] [Related]
31. [Clinical use of botulinum toxin]. Jost WH. Nervenarzt; 2008 Jun 08; 79 Suppl 1():9-14. PubMed ID: 18927958 [Abstract] [Full Text] [Related]
32. Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Walter U, Dressler D. Expert Rev Neurother; 2014 Aug 08; 14(8):923-36. PubMed ID: 25046267 [Abstract] [Full Text] [Related]
33. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis]. Aguilar-Rebolledo F, Hernández-Sánchez J, Rayo-Mares D, Soriano-Fonseca F, García-Muñoz L, Ruiz-Ponce J, Garrido-Ramírez E. Gac Med Mex; 2001 Aug 08; 137(5):403-11. PubMed ID: 11692809 [Abstract] [Full Text] [Related]
34. [Mechanism of therapy effects by botulinum neurotoxin]. Alajbegović A, Alajbegović S, Resić H. Med Arh; 2008 Aug 08; 62(1):53-5. PubMed ID: 18543757 [Abstract] [Full Text] [Related]
35. Unlabeled uses of botulinum toxins: a review, part 2. Cheng CM, Chen JS, Patel RP. Am J Health Syst Pharm; 2006 Feb 01; 63(3):225-32. PubMed ID: 16434781 [Abstract] [Full Text] [Related]
36. Botulinum toxin type A in children. New indication for limb spasticity. Prescrire Int; 2011 Mar 01; 20(114):68. PubMed ID: 21648226 [No Abstract] [Full Text] [Related]
37. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition]. Budrewicz S, Koszewicz M, Góral M. Neurol Neurochir Pol; 2003 Mar 01; 37 Suppl 5():55-60. PubMed ID: 15098332 [Abstract] [Full Text] [Related]
38. Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up. On AY, Kirazli Y, Kismali B, Aksit R. Am J Phys Med Rehabil; 1999 Mar 01; 78(4):344-9. PubMed ID: 10418840 [Abstract] [Full Text] [Related]
39. Botulinum toxin A treatment of adult upper and lower limb spasticity. Hesse S, Brandi-Hesse B, Bardeleben A, Werner C, Funk M. Drugs Aging; 2001 Mar 01; 18(4):255-62. PubMed ID: 11341473 [Abstract] [Full Text] [Related]
40. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation. Thussu A, Barman CR, Prabhakar S. Neurol India; 1999 Sep 01; 47(3):206-9. PubMed ID: 10514580 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]